LI Li-xia1,HUANG Cheng-ke2,SUN Chao-rong1,HU Song-hao1,LU Xiao-tong1
1.Pharmaceutical Department in Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine,Shanghai 200092,China; 2.Pharmaceutical Department in Second Hospital Affiliated to Wenzhou Medical College,Wenzhou 325027,China
Abstract��
OBJECTIVE To provide information for clinical pharmacists who participate in personalized pharmacotherapy for patients with liver dysfunction in intensive care units (ICU) and perform individualized medication monitoring. METHODS Literatures and instructions for medicines used commonly in ICU and medicines harmful to liver were searched and summarized. RESULTS AND CONCLUSION Clinical pharmacists should focus on personalized medicine therapy for special patients in ICU and provide personalized medicine services.
LI Li-Xia-,
HUANG Cheng-Ke-,
SUN Chao-Rong- etc
.Personalized Medicine Policy for Patients with Hepatic Insufficiency in Intensive Care Units[J] Chinese Pharmaceutical Journal, 2013,V48(17): 1493-1496
��
[1]
FDA.Guidance for Industry:pharmacokineties in patients with impaired hepatic function:study design,data analysis,and impact on dosing and labeling.FDA,2003-5.http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072123.pdf. EMA.Guideline on the evaluation of the pharmacokinetics of medicine products in impairment hepatic function.London: /european Medicines Agency,2005-2-17.http://www.ema.europa.eu/docs/cn GB/document library/Scientific guideline/2009/09/WC500003122.PDF. DONG H Y.The practice of clinical pharmacy services in the ICU.Chin Hosp Pharm J(�й�ҽԺҩѧ��־),2008,28(20):1791-1792. ZHAO R,WU C Y,WU L Y.Intensive care unit clinical pharmacist mode.Chin Pharm J(�й�ҩѧ��־),2007,42(8):639-640. DONG M.Selection of nutritional formulations of the patients withliver injury during perioperation.Chin J Practi Surg(�й�ʵ�������־),2012,32(2):117-119. WU J.The application of safety and reasonable about PPIS in digestive system drugs.China Prac Med(�й�ʵ��ҽҩ),2011,6(18):174-175. LIN P R,HUANG Y G.The possible risks of prolonged infusion of propofol-propofol infusion syndrome.J Clin Anesthesiol(�ٴ�����ѧ��־),2004,20(4):250-252. WU Z L,SHE S Z,XU L X,et al.Pharmacodynamics of rocuronium in patients with chronic liver dysfunction.Chin J Anesthesiol(�л�����ѧ��־),2005,25(9):653-656.
2013, Vol. 48 